Emergency Contraceptive Pills Market by Type (Antiprogestin, Combination Pills, Progesterone Pills), Category (Branded, Generic), Age Group, Distribution - Global Forecast 2024-2030

[198 Pages Report] The Emergency Contraceptive Pills Market size was estimated at USD 1.02 billion in 2023 and expected to reach USD 1.08 billion in 2024, at a CAGR 6.49% to reach USD 1.58 billion by 2030.

Emergency contraceptive pills, commonly called the “morning-after pill,” are a type of birth control method used to prevent pregnancy. Emergency contraceptive pills are not intended for regular use and should not be used as a substitute for other forms of contraception. The use of emergency contraceptive pills has increased in past years to prevent unintended pregnancies. In addition, the supportive government and non-profit organization’s efforts to increase awareness toward the use of emergency contraceptive pills have contributed to the market growth. The side effects of emergency contraceptive pills and concerns associated with the effectiveness of pills limit their use among the women of the U.S. population. However, the ongoing research and development activities for new product developments and the emergence of contraceptive pills on online channels are expected to create growth opportunities for the market in the U.S.

The emergency contraceptive pills market in the United States is rapidly growing owing to the ability of pills to prevent unintended pregnancies, supportive government awareness programs, and ongoing advancements in product portfolios. As per the National Institute of Health (NIH), around 25% of women aged between 15 to 44 currently using contraception reported consuming the pill as their choice. Policies and regulations promote access to comprehensive contraceptive care and methods as a critical part of women's health care, ensuring the availability of these pills at reasonable and accessible contraceptive care and procedures. Moreover, the increasing awareness and availability of novel product portfolios online are expected to drive the growth of the emergency contraceptive pills market in the coming years.

The market dynamics represent an ever-changing landscape of the Emergency Contraceptive Pills Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Emergency Contraceptive Pills Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Emergency Contraceptive Pills Market.

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Emergency Contraceptive Pills Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

The value chain of the Emergency Contraceptive Pills Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.

The pricing analysis comprehensively evaluates how a product or service is priced within the Emergency Contraceptive Pills Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Emergency Contraceptive Pills Market.

The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Emergency Contraceptive Pills Market.

The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Emergency Contraceptive Pills Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.

The trade analysis of the Emergency Contraceptive Pills Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.

The regulatory framework analysis for the Emergency Contraceptive Pills Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Emergency Contraceptive Pills Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Emergency Contraceptive Pills Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

• Government of the United States Signed an Executive Order Expanding Access to Birth Control

  The government of the United States signed an executive order to enhance and safeguard access to contraception. The government has emphasized that contraception is a crucial aspect of reproductive healthcare, particularly in light of the women's access crisis that followed the above ruling. The government's order also mandates that private health insurers cover all FDA-approved contraceptives without requiring a copay by the Affordable Care Act. [Published On: 2023-06-23]

• Gedeon Richter Acquires Oral Contraceptive Range from Consilient Health

  Gedeon Richter PLC acquired Consilient Health’s exclusive marketing and distribution rights to an oral contraceptive range of branded generics. Under the terms of the transfer, Gedeon Richter has become the marketing authorization holder in the UK for all the products within the field. [Published On: 2023-06-14]

• Health-Care Startup Up Acquires Patient Records of Bankrupt Birth Control Provider

  Thirty Madison, Inc. acquired the Pill Club’s patient records, patient lists, prescription files, and other customer and insurance information for USD 32.3 million. With the acquisition, the company aimed to ensure continuity of care for over 100,000 patients through its Nurx brand, a direct-to-consumer women’s health company best known for its online birth control. [Published On: 2023-06-13]

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Emergency Contraceptive Pills Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

The report delves into recent significant developments in the Emergency Contraceptive Pills Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Afaxys Pharma, LLC, Amneal Pharmaceuticals, Inc., Apotex Inc., Aurobindo Pharma Limited, Bayer AG, Bionpharma Inc., Cipla Limited, Combe Incorporated, Curae Pharma360 Inc., Foundation Consumer Healthcare, LLC, Gedeon Richter PLC, Glenmark Pharmaceuticals Limited, Julie Product Inc., Lupin Limited, Mankind Pharma Ltd., Merck & Co., Inc., Northstar Rx LLC, Perrigo Company plc, Pfizer, Inc., Piramal Enterprises Ltd., Rapha Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited, Syzygy Healthcare Solutions, LLC, Viatris Inc., Wockhardt USA LLC, and Xiromed, LLC.

This research report categorizes the Emergency Contraceptive Pills Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Type
  • Antiprogestin
  • Combination Pills
  • Progesterone Pills
• Category
  • Branded
  • Generic
• Age Group
  • 15-24
  • 25-34
  • 35-44
  • 45 and Above
• Distribution
  • Offline
  • Online

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

1. What is the current market size and projected growth?
2. Which products, segments, applications, and regions offer promising investment opportunities?
3. What are the prevailing technology trends and regulatory frameworks?
4. What is the market share and positioning of the leading vendors?
5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?